Ulf Jönsson, co-founder and CEO of Biacore, has been appointed by PharmaDiagnostics NV as non-executive director.
David Rickets, CEO pf PharmaDiagnostics, said: “Ulf Jönsson’s decision to join PharmaDiagnostics sends a powerful signal of confidence to the market.”
He continued: “Ulf's experience in founding a technology company, driving its growth and leading it as CEO will be of significant help to our growth plans, and his expertise in the label-free market will contribute to all aspects of our development strategy. I am delighted that he is joining us and look forward to working with him.”
“PharmaDiagnostics' SoPRano platform and its supporting technology has the potential to revolutionize label-free screening,” said Jönsson.
“It is the only company that enables label-free screening without recourse to expensive dedicated instrumentation, and I look forward to bringing my expertise and experience to bear on helping the team successfully develop and market its innovative technology."
